首页> 外文期刊>核医学 >術後分化型甲状腺癌における~(99m)TlTc-MIBIシンチグラフィの転移病巣検出能の検討~(131)I,~(201)T1との比較-
【24h】

術後分化型甲状腺癌における~(99m)TlTc-MIBIシンチグラフィの転移病巣検出能の検討~(131)I,~(201)T1との比較-

机译:检查术后分化甲状腺癌 - (131)I,〜(201)与T1-相比(99米)TLTC-MIBI闪烁扫描能力的检查

获取原文
获取原文并翻译 | 示例
           

摘要

~(99m)Tc-MIBIの分化型甲状腺癌転移病巣の検出能について~(131)I,(201)T1と比較した·対象は術後分化型甲状腺癌患者40例で,転移あり25例,転移なし15例であった.陽性率は~(99m)Tc-MIBIで68%,~(131)Iで84%, ~(201)T1で60%であった.転移リンパ節の陽性率は(99m)~Tc-MIBIで56%, ~(131)Iで78%, ~(201)T1で39%,肺転移の陽性率は)~(99m)Tc-MIBIで46%,~(131)Iで82%, ~(201)T1で55%であった. ~(I31)I陰性病巣に~(201)T1 ~(99m)Tc-MIBIの集積が認められる症例の頻度は,肺,リンパ節,肝,骨,脳いずれの臓器についても30%以下であった. ~(131)Iの集積陽性群,陰性群ともに~(99n)Tc-MIBIまたは(201)~T1が集積陽性を呈する群では,陰性群と比較して血清サイログロブリン濃度が高値を示した.~(99m)Tc-MIBIでは~(201)T1同様に~(131)Iと比較して甲状腺癌転移病巣の検出能が低かったが, ~(131)Iシンチグデフイ所見が陰性でかつ血清サイログロブリン濃度が高値を示す場合は,甲状腺癌転移病巣の描画法として有用な診断法と考えられた.Detectability of metastasis in differentiated thyroid cancer using technetium-99m-methoxyisobutyl isoni-trile (~(99m)Tc-MIBI) was compared with that of ~(131)I and ~(201)T1. Forty patients after total thyroidectomy were evaluated. The scan results were compared with those of ~(131)I and ~(201)T1 whole body scintigraphy per patient. The positive rate was 68% in ~(99m)Tc-MIBI, 84% in ~(131)I, 60% in ~(201)T1 respectively. As to the lymph node metastasis, the positive rates were 56% in ~(99m)Tc-MIBI, 78% in ~(131)I, 39% in ~(201)T1. In lung metastasis, the positive rate was 46% in ~(99m)Tc-MIBI, 82% in ~(131)I and 55% in ~(201)T1.Serum thyroglobulin (Tg) was significantly higher in ~(201)T1 and/or ~(99m)Tc-MIBI positive group compared to that of negative group independent of ~(131)I scan results.Although the detectability of both ~(99m)Tc-MIBI and ~(201)T1 were inferior to that of ~(131)I, 9 to 22% of metastasis were detected only by these radiopharmaceuticals. Both ~(99m)Tc-MIBI and ~(201)T1, therefore, should be used in cases with high serum Tg even with negative ~(131)I uptake. Basing on the fact there was no prominent difference between ~(99m)Tc-MIBI and ~(201)T1 in the detectability of metastasis, ~(99m)Tc-MIBI might be more suitable tracer because of better quality image.
机译:(99 M)TC-MIBI分化型甲状腺癌转变目标检测能力Sitial状况至(131)I,(201)T1·主题是40例术后分化型甲状腺癌,和25例,它是15例无转移的阳性率为(99米)的Tc-MIBI 68%,并且在(131)I,于(201)T1。过渡淋巴结的阳性率是(99米)到56%在TC- 60% MIBI,78%到(131)I,在(201)T1,肺转移的阳性率)〜39%(99米)46%与TC-MIBI,〜(131(I31)I.(I31)I. (I31)。I.(I31)。淋巴结,肝,骨和脑器官也是30%或更小。(131)I的集成阳性组,阴性组(99N)TC-MIBI或(201)到T1被聚集正在组提出,血清thiroglobulin浓度高相比负性基团。〜(99米)TC-MIBI〜(201)类似于(201)T1以检测甲状腺癌过渡病变相比于(131) I,低,但如果Sintig的Defi火发现是否定的,并且血清咽喉浓度高时,它被认为是如使用锝-99m绘图甲状腺癌过渡病灶转移的。可检测在分化型甲状腺癌的方法有用的诊断方法-methoxyisobutyl isoni-trile(〜(99米)的Tc-MIBI)与〜的比较(131)I和〜(201)T1。40名患者全甲状腺后进行评价。该扫描结果与进行比较〜 (131)I和〜(201)T1全身显像每病人。阳性率为68%,以(99 M)TC-MIBI,84%IN至(131)I,60%IN(201)T1分别。至于淋巴NO德转移是56%IN〜(99米)TC-MIBI,78%IN到(131)I,39%IN-(201)T1。在肺转移,阳性率为46%(99米)TC-MIBI, 82%IN(131)I和55%IN(201)T1.Serum甲状腺球蛋白(TG)显着较高IN(201)T 1和/或- (99M)TC-MIBI阳性组比较相比,阴性组独立〜(131)的两个I扫描Results.although可探测〜(99米)TC-MIBI和〜(201)T1是劣于〜(131)的I,转移的9%至22%只被这些放射性药物检测。既〜(99米)TC-MIBI和〜(201)T1,因此,应该使用与高血清TG即使负例〜(131)I摄取。立足于这样的事实,没有突出差异〜之间(99米) TC-MIBI和〜(201)中的T1转移的可检测性,〜(99米)TC-MIBI可能更适合TRACER BECAUSE更佳影像质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号